Patented Medicines (Notice of Compliance) Regulations, SOR/93-133

Section 8.1

Cite as Patented Medicines (Notice of Compliance) Regulations, SOR/93-133, s. 8.1 · current to July 24, 2025 · regulation last amended January 1, 2025

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

A person who files a submission for a notice of compliance or a supplement to a submission for a notice of compliance in respect of a drug and who has reasonable grounds to believe that the making, constructing, using or selling of the drug might be alleged to infringe a patent or a certificate of supplementary protection is, if the submission or supplement directly or indirectly compares the drug with, or makes reference to, another drug marketed in Canada, an interested person (a) for the purpose of subsection 60(1) of the Patent Act with respect to bringing an action for a declaration that the patent or any claim in the patent is invalid or void; or (b) for the purpose of subsection 125(1) of that Act with respect to bringing an action for a declaration that the certificate of supplementary protection or any claim in the patent set out in it is invalid or void.
Read the Patented Medicines (Notice of Compliance) Regulations on the Justice Laws Website ↗

Made under Patent Act, R.S.C. 1985, c. P-4.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.